181 related articles for article (PubMed ID: 34728115)
1. Unusual severe radiation-induced toxicity in a patient with discoid lupus erythematosus: A case report and critical review of the literature.
Allali S; Chasset F; Kirova Y; Saint-Martin C; Moguelet P; Fourquet A; Beddok A
Cancer Radiother; 2022 Jun; 26(4):594-598. PubMed ID: 34728115
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
Grönhagen CM; Fored CM; Granath F; Nyberg F
Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
[TBL] [Abstract][Full Text] [Related]
3. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.
Braunstein I; Klein R; Okawa J; Werth VP
Br J Dermatol; 2012 May; 166(5):971-5. PubMed ID: 22242767
[TBL] [Abstract][Full Text] [Related]
4. Interventions for cutaneous disease in systemic lupus erythematosus.
Hannon CW; McCourt C; Lima HC; Chen S; Bennett C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007478. PubMed ID: 33687069
[TBL] [Abstract][Full Text] [Related]
5. Association Between Drug Use and Subsequent Diagnosis of Lupus Erythematosus.
Haugaard JH; Kofoed K; Gislason G; Dreyer L; Egeberg A
JAMA Dermatol; 2020 Nov; 156(11):1199-1207. PubMed ID: 32876672
[TBL] [Abstract][Full Text] [Related]
6. Characterization of clinical photosensitivity in cutaneous lupus erythematosus.
Foering K; Chang AY; Piette EW; Cucchiara A; Okawa J; Werth VP
J Am Acad Dermatol; 2013 Aug; 69(2):205-13. PubMed ID: 23648190
[TBL] [Abstract][Full Text] [Related]
7. Rapid efficacy of anifrolumab across multiple subtypes of recalcitrant cutaneous lupus erythematosus parallels changes in discrete subsets of blood transcriptomic and cellular biomarkers.
Carter LM; Wigston Z; Laws P; Vital EM
Br J Dermatol; 2023 Jul; 189(2):210-218. PubMed ID: 36944572
[TBL] [Abstract][Full Text] [Related]
8. Immunogenetics of cutaneous lupus erythematosus.
Hersh AO; Arkin LM; Prahalad S
Curr Opin Pediatr; 2016 Aug; 28(4):470-5. PubMed ID: 27386968
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States.
Jarukitsopa S; Hoganson DD; Crowson CS; Sokumbi O; Davis MD; Michet CJ; Matteson EL; Maradit Kremers H; Chowdhary VR
Arthritis Care Res (Hoboken); 2015 May; 67(6):817-28. PubMed ID: 25369985
[TBL] [Abstract][Full Text] [Related]
10. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
[TBL] [Abstract][Full Text] [Related]
11. Black patients with cutaneous lupus are associated with positive family history of cutaneous lupus and systemic lupus.
Keum H; Brown LS; Chong BF
Lupus Sci Med; 2022 Dec; 9(1):. PubMed ID: 36600582
[TBL] [Abstract][Full Text] [Related]
12. New insights into the progression from cutaneous lupus to systemic lupus erythematosus.
Zhou W; Wu H; Zhao M; Lu Q
Expert Rev Clin Immunol; 2020 Aug; 16(8):829-837. PubMed ID: 32746644
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of cutaneous lupus erythematosus and the associated risk of systemic lupus erythematosus: a nationwide cohort study in Denmark.
Petersen MP; Möller S; Bygum A; Voss A; Bliddal M
Lupus; 2018 Aug; 27(9):1424-1430. PubMed ID: 29788808
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K
Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous lupus erythematosus is associated with an increased risk of cardiac and vascular diseases: a large-scale, propensity-matched global retrospective cohort study.
Olbrich H; Kridin K; Zirpel H; Sadik CD; Terheyden P; Thaçi D; Ludwig RJ; Boch K
EBioMedicine; 2023 Jul; 93():104639. PubMed ID: 37285617
[TBL] [Abstract][Full Text] [Related]
16. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study.
Haugaard JH; Dreyer L; Ottosen MB; Gislason G; Kofoed K; Egeberg A
J Am Acad Dermatol; 2021 Apr; 84(4):930-937. PubMed ID: 33321159
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Risk of Autoimmune Diseases other than Systemic Lupus Erythematosus in Cutaneous Lupus Erythematosus-Alone Patients: A 10-Year Nationwide Cohort Study.
Lin TL; Wu CY; Juan CK; Chang YT; Chen YJ
Dermatology; 2022; 238(1):92-100. PubMed ID: 34062538
[TBL] [Abstract][Full Text] [Related]
18. Management of cutaneous manifestations of lupus erythematosus: A systematic review.
Fairley JL; Oon S; Saracino AM; Nikpour M
Semin Arthritis Rheum; 2020 Feb; 50(1):95-127. PubMed ID: 31526594
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients.
Chanprapaph K; Tubtieng I; Pratumchat N; Thadanipon K; Rattanakaemakorn P; Suchonwanit P
Lupus; 2021 Apr; 30(5):785-794. PubMed ID: 33554715
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous manifestations and serological findings in 260 patients with systemic lupus erythematosus.
Grönhagen CM; Gunnarsson I; Svenungsson E; Nyberg F
Lupus; 2010 Sep; 19(10):1187-94. PubMed ID: 20501526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]